Antiviral drug resistance in herpes simplex virus

Advances in Experimental Medicine and Biology

Volumn 394, Issue , 1996, Pages 49-57

  Coen, Donald M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERPES; SIMPLEXVIRUS;

ACICLOVIR; FOSCARNET;

ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; DRUG RESISTANCE; ENZYME ACTIVE SITE; HERPES SIMPLEX; HUMAN; PRIORITY JOURNAL; VIRUS LATENCY;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS; SIMPLEXVIRUS;

EID: 0029916636     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9209-6_7     Document Type: Article

References (17)

1. Larder BA and Darby G Virus drug resistance: mechanisms and consequences Antiviral Res 1984 4,1-42.
2. Coen DM. General aspects of virus drug resistance with special reference to herpes simplex virus. J Antimicrob Chemother 1986; 18B:1-10.
3. Coen DM. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy. Antiviral Res 1991; 15:287-300.
4. Chatis PA and Crumpacker CS Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother 1992; 36: 1589-1595.
5. Coen DM. Drug resistance in herpesviruses. International Antiviral News 1993; 1: 98-99.
6. Field A.K. and Biron, K.K. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs Clin Microb Revs 1994; 7: 1-13.
7. Coen DM Acyclovir-resistant, pathogenic herpesviruses. Trends Microbiol 1994; 2: 481-485.
8. Martin JL, Brown CE, Matthews-Davis N, Reardon JE. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 1994;38:2743-2749.
9. Reardon JE & Spector T. Herpes simplex virus type 1 DNA polymerase: mechanism of inhibition by acyclovir triphosphate. J Biol Chem 1989; 264: 7405-7411.
10. Chiou HC, Kumura K, Hu A, Kerns KM, Coen DM. Penciclovir-resistance mutations in the herpes simplex virus DNA polymerase gene. Antiviral Chem Chemother. 1995;6:281-288.
11. Kost, R.G., Hill, E.L. Tigges M. et al. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient N Engl J Med 329: 1777-1782.
12. Hwang CBC, Horsburgh B, Pelosi E, et al. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant Proc Natl Acad Sci USA 1994; 91: 5461-5465.
13. Wang Y, Woodward S, Hall JD. Use of suppressor analysis to identify DNA polymerase mutations in herpes simplex virus which affect deoxynucleoside triphosphate substrate specificity J Virol 1992; 66: 1814-1816.
14. Kosz-Venenchak M, Coen DM, Knipe DM. Restricted expression of herpes simplex virus lytic genes during establishment of latent infection. J Virol 1990; 64: 5396-5402.
15. Kosz-Vnenchak M, Jacobson J, Coen DM, et al. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol 1993; 67: 5383-5393.
16. Irmiere AF, Manos MM, Jacobson JG, et al. Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability. Virology 1989; 168: 210-220.
17. Coen DM, Irmiere AF, Jacobson JG, et al. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Virology. 1989; 168:221-231.